Clinical Trial Update: Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a Phase 3 study evaluating milnacipran's effect on pain processing and fMRI activation in people with fibromyalg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 3 | Status: TERMINATED | Results posted: 2010-07-01